Potent Antimalarial 2-Pyrazolyl Quinolone bc 1 (Qi) Inhibitors with Improved Drug-like Properties.

A series of 2-pyrazolyl quinolones has been designed and synthesized in 5-7 steps to optimize for both in vitro antimalarial potency and various in vitro drug metabolism and pharmacokinetics (DMPK) features. The most potent compounds display no cross-resistance with multidrug resistant parasite strains (W2) compared to drug sensitive strains (3D7), with IC50 (concentration of drug required to achieve half maximal growth suppression) values in the range of 15-33 nM. Furthermore, members of the series retain moderate activity against the atovaquone-resistant parasite isolate (TM90C2B). The described 2-pyrazoyl series displays improved DMPK properties, including improved aqueous solubility compared to previously reported quinolone series and acceptable safety margin through in vitro cytotoxicity assessment. The 2-pyrazolyl quinolones are believed to bind to the ubiquinone-reducing Qi site of the parasite bc 1 complex, which is supported by crystallographic studies of bovine cytochrome bc 1 complex.

[1]  Jacob Bodilsen,et al.  [Plasmodium falciparum]. , 2022, Ugeskrift for laeger.

[2]  Maojun Yang,et al.  Target Elucidation by Cocrystal Structures of NADH-Ubiquinone Oxidoreductase of Plasmodium falciparum (PfNDH2) with Small Molecule To Eliminate Drug-Resistant Malaria. , 2017, Journal of medicinal chemistry.

[3]  A. Vaidya,et al.  Subtle Changes in Endochin-Like Quinolone Structure Alter the Site of Inhibition within the Cytochrome bc1 Complex of Plasmodium falciparum , 2015, Antimicrobial Agents and Chemotherapy.

[4]  S. Antonyuk,et al.  Antimalarial 4(1H)-pyridones bind to the Qi site of cytochrome bc1 , 2015, Proceedings of the National Academy of Sciences.

[5]  R. Bauer,et al.  1,2-Substituted 4-(1H)-Quinolones: Synthesis, Antimalarial and Antitrypanosomal Activities in Vitro , 2014, Molecules.

[6]  C. Pannecouque,et al.  Exploiting the anti-HIV 6-desfluoroquinolones to design multiple ligands. , 2014, Bioorganic & medicinal chemistry.

[7]  Richard M. Beteck,et al.  Recent progress in the development of anti-malarial quinolones , 2014, Malaria Journal.

[8]  Marco Biasini,et al.  SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..

[9]  D. Kyle,et al.  4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-Ones Prevent the Transmission of Plasmodium falciparum to Anopheles freeborni , 2013, Antimicrobial Agents and Chemotherapy.

[10]  Yuexin Li,et al.  Quinolone-3-Diarylethers: A New Class of Antimalarial Drug , 2013, Science Translational Medicine.

[11]  D. Lalloo,et al.  Antimalarial pharmacology and therapeutics of atovaquone , 2013, The Journal of antimicrobial chemotherapy.

[12]  D. Kyle,et al.  Lead optimization of 3-carboxyl-4(1H)-quinolones to deliver orally bioavailable antimalarials. , 2012, Journal of medicinal chemistry.

[13]  J. Hemingway,et al.  Generation of quinolone antimalarials targeting the Plasmodium falciparum mitochondrial respiratory chain for the treatment and prophylaxis of malaria , 2012, Proceedings of the National Academy of Sciences.

[14]  Peter D Gibbons,et al.  Identification, Design and Biological Evaluation of Bisaryl Quinolones Targeting Plasmodium falciparum Type II NADH:Quinone Oxidoreductase (PfNDH2) , 2012, Journal of medicinal chemistry.

[15]  H. Ranson,et al.  Cytochrome b Mutation Y268S Conferring Atovaquone Resistance Phenotype in Malaria Parasite Results in Reduced Parasite bc1 Catalytic Turnover and Protein Expression , 2012, The Journal of Biological Chemistry.

[16]  Aurélien Grosdidier,et al.  SwissDock, a protein-small molecule docking web service based on EADock DSS , 2011, Nucleic Acids Res..

[17]  Kelly Chibale,et al.  The state of the art in anti-malarial drug discovery and development. , 2011, Current topics in medicinal chemistry.

[18]  N. Meanwell.  Synopsis of some recent tactical application of bioisosteres in drug design. , 2011, Journal of medicinal chemistry.

[19]  Minoru Ishikawa,et al.  Improvement in aqueous solubility in small molecule drug discovery programs by disruption of molecular planarity and symmetry. , 2011, Journal of medicinal chemistry.

[20]  Kirandeep Kaur,et al.  Quinolines and structurally related heterocycles as antimalarials. , 2010, European journal of medicinal chemistry.

[21]  Jianliang Xiao,et al.  Direct acylation of aryl bromides with aldehydes by palladium catalysis. , 2008, Journal of the American Chemical Society.

[22]  Andrew Owen,et al.  Acridinediones: Selective and Potent Inhibitors of the Malaria Parasite Mitochondrial bc1 Complex , 2008, Molecular Pharmacology.

[23]  David Hinrichs,et al.  Antimalarial quinolones: synthesis, potency, and mechanistic studies. , 2008, Experimental parasitology.

[24]  G. Biagini,et al.  The malaria parasite type II NADH:quinone oxidoreductase: an alternative enzyme for an alternative lifestyle. , 2007, Trends in parasitology.

[25]  Joanne M. Morrisey,et al.  Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.

[26]  G. Biagini,et al.  Functional Characterization and Target Validation of Alternative Complex I of Plasmodium falciparum Mitochondria , 2006, Antimicrobial Agents and Chemotherapy.

[27]  A. Vaidya,et al.  Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial Parasite* , 1997, The Journal of Biological Chemistry.

[28]  R. Siva,et al.  Synthesis of 4-Hydroxy-2(1H)-Quinolone Derived Chalcones, Pyrazolines and Their Antimicrobial, In Silico Antimalarial Evaluations , 2014, Applied Biochemistry and Biotechnology.

[29]  H. Webster,et al.  Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. , 1996, The American journal of tropical medicine and hygiene.

[30]  J. M. Stephen,et al.  Tetrahydroacridones and related compounds as antimalarials. , 1947, Journal of the Chemical Society.

[31]  J. M. Stephen,et al.  192. Tetrahydroacridones and related compounds as antimalarials , 1947 .